Natixis Advisors LLC Has $878,000 Position in Option Care Health, Inc. (NASDAQ:OPCH)

Natixis Advisors LLC decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 57.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 37,852 shares of the company's stock after selling 50,899 shares during the period. Natixis Advisors LLC's holdings in Option Care Health were worth $878,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the stock. UMB Bank n.a. boosted its stake in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after acquiring an additional 346 shares during the last quarter. Quarry LP boosted its position in shares of Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company's stock worth $107,000 after purchasing an additional 2,628 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after purchasing an additional 681 shares in the last quarter. Venturi Wealth Management LLC grew its holdings in shares of Option Care Health by 2,621.3% in the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock valued at $110,000 after buying an additional 4,561 shares during the period. Finally, TD Private Client Wealth LLC increased its position in shares of Option Care Health by 21.4% in the 3rd quarter. TD Private Client Wealth LLC now owns 5,723 shares of the company's stock valued at $179,000 after buying an additional 1,007 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Remove Ads

Analyst Ratings Changes

A number of research firms have issued reports on OPCH. Barrington Research boosted their target price on Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. JMP Securities reiterated a "market outperform" rating and issued a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. UBS Group began coverage on Option Care Health in a research note on Thursday, December 5th. They set a "neutral" rating and a $26.00 target price for the company. JPMorgan Chase & Co. lifted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Finally, Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and an average price target of $33.00.

Option Care Health Stock Down 1.3 %

Shares of OPCH traded down $0.47 during mid-day trading on Friday, hitting $34.73. 1,378,809 shares of the company's stock were exchanged, compared to its average volume of 1,713,822. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The company has a market cap of $5.70 billion, a PE ratio of 29.18, a P/E/G ratio of 2.30 and a beta of 1.33. The company has a 50-day simple moving average of $32.47 and a 200 day simple moving average of $28.38.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.64% of the stock is owned by corporate insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.